Article
Molecular dynamics simulation studies of the wild type and E92Q/N155H mutant of Elvitegravir-resistance HIV-1 integrase.
Interdisciplinary sciences, computational life sciences - 1 Mar 2015
Chen Qi, Cheng Xiaolin, Wei Dongqing, Xu Qin
Abstract excerpt
Although Elvitegravir (EVG) is a newly developed antiretrovirals drug to treat the acquired immunodeficiency syndrome (AIDS), drug resistance has already been found in clinic, such as E92Q/N155H and Q148H/G140S. Several structural investigations have already been reported to reveal the molecular mechanism of the drug resistance. As full length crystal structure for HIV-1 integrase is still unsolved, we herein use...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
